Clinical Management of Hereditary Hemochromatosis: Phlebotomy vs. Erythrocytoapheresis
NCT00440986 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2007-03-01
Summary
The purpose of study is to determine the best and durable choice of treatment between phlebotomy and eritrocytoapheresis in the medium- and long-term clinical management of HH
Conditions
- Hereditary Hemochromatosis
Interventions
- PROCEDURE
-
Eritrocytoapheresis
Sponsors & Collaborators
-
San Filippo Neri General Hospital
lead OTHER
Principal Investigators
-
Francesco Equitani, M.D. · San Filippo Neri General Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2003-04-30
- Completion
- 2006-12-31
Countries
- Italy
Study Locations
More Related Trials
-
Quality and Biologic Characteristics of Red Blood Concentrates Obtained From Individuals With Elevated Ferritin.
NCT05742035 ·Status: UNKNOWN ·Phase: NA
-
Hemochromatosis--Genetic Prevalence and Penetrance
NCT00006312 ·Status: COMPLETED
-
Observational Study for Patients With Hemoglobinopathies and Rare Inherited Anemia and Covid 19
NCT04746066 ·Status: RECRUITING
-
Statistical Basis for Hemochromatosis Screening
NCT00005559 ·Status: COMPLETED
-
Safety of FCM vs. Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum Patients
NCT00548860 ·Status: COMPLETED ·Phase: PHASE3
-
Transferrin Saturation and Asthenia in Hemochromatosis
NCT03356548 ·Status: COMPLETED
-
Monitoring of Erythroid Lineage Specific Chimerism Following Allogeneic Hematopoietic Transplantation for Thalassemia Major
NCT00480506 ·Status: COMPLETED
-
Hibiscus Sabdariffa and Centella Asiatica in the Treatment of Anemia by Iron Deficiency
NCT01414374 ·Status: COMPLETED ·Phase: PHASE3
-
Characteristics of Hgb C Carriers in Northern Israel and Clinical Features Among Hgb Homozygous
NCT00481260 ·Status: COMPLETED
-
The Impact of Red Packed Cells Transfusion on the Main Biological Markers to Determine the Etiology of Anemias
NCT01409967 ·Status: COMPLETED
-
Cohort of Patients With Rare Iron Overloads Excluding C282Y Homozygosity
NCT02619955 ·Status: COMPLETED
-
Study of the Role of Genetic Modifiers in Hemoglobinopathies
NCT05799118 ·Status: RECRUITING
-
Bone Status on Patients With Genetic Hemochromatosis: a 3 Years Descriptive and Evolutionary Study
NCT01556360 ·Status: COMPLETED
-
Atrial Fibrillation in Beta-Thalassemia
NCT05508932 ·Status: RECRUITING
-
Absorption of Heme and Non-Heme Iron in Pregnant and Non-pregnant Women and Mechanisms of Fetal Iron Transfer
NCT01019096 ·Status: COMPLETED
-
A Trial of 2 'Point of Care' Diagnostic Methods to Improve Detection and Treatment of Anaemia in African Children
NCT00439595 ·Status: COMPLETED ·Phase: NA
-
Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding
NCT00395993 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing the Iron Substitution With the Medicinal Products Ferinject or Monofer
NCT02905539 ·Status: COMPLETED ·Phase: PHASE4
-
Cardiac Function in Patients With Hereditary Hemochromatosis
NCT00068159 ·Status: COMPLETED
-
Detection of β Thalassemia Carriers by Red Cell Parameters Obtained From the H2 Automatic Counter
NCT00481221 ·Status: UNKNOWN
-
Hereditary Spherocytosis and Vascular Function
NCT04451785 ·Status: COMPLETED ·Phase: NA
-
Natural History Study of Adult Patients With Paroxysmal Nocturnal Hemoglobinuria of High-risk Hemolysis in China
NCT05125341 ·Status: COMPLETED
-
HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity
NCT02435901 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Hematocrit to Hemoglobin Ratio and Red Blood Cell Distribution Width in Polycythemia Vera and Secondary Erythrocytosis.
NCT05993065 ·Status: UNKNOWN
-
National Exhaustive Cohort of Hereditary Stomatocytoses and Other Channelopathies Affecting the Red Blood Cell
NCT04778657 ·Status: RECRUITING